National Health Commission: Bivalent vaccine can prevent more than 70% of cervical cancer

This morning, the National Health and Medical Commission introduced at a press conference that five HPV vaccines have been approved for registration in my country.

Currently available HPV vaccines in my country include bivalent, quadrivalent and 9-valent HPV vaccines, which are used in women aged 9 to 45 years old. The high-risk HPV types that cause cervical cancer are 16 and 18 Subtype, so bivalent vaccine can prevent more than 70% of cervical cancer.

The sooner the HPV vaccine is vaccinated, the better the effect. Under the current tight supply of HPV vaccine, there is no need to wait for a higher-priced vaccine And miss the best vaccination time.

Source: @ Knight Island

Process editor: tf025